Anderson Schock
Stock Analyst at B. Riley Securities
(3.91)
# 1,974
Out of 5,078 analysts
42
Total ratings
59.5%
Success rate
14.3%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VREX Varex Imaging | Downgraded: Hold | $18 → $19 | $18.42 | +2.61% | 5 | Aug 10, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $10 → $8 | $2.13 | +275.59% | 2 | Aug 6, 2026 | |
| INFU InfuSystem Holdings | Rated: Buy | $12 → $20 | $13.94 | +43.47% | 3 | Aug 5, 2026 | |
| XGN Exagen | Rated: Buy | $8 → $12 | $7.27 | +65.06% | 5 | Aug 5, 2026 | |
| ANIK Anika Therapeutics | Reiterated: Buy | $18 → $21 | $21.42 | -1.96% | 4 | Jul 30, 2026 | |
| NUTX Nutex Health | Initiated Coverage: Buy | $290 | $209.59 | +38.37% | 1 | Jun 26, 2026 | |
| CLPT ClearPoint Neuro | Reiterated: Buy | $20 → $30 | $9.14 | +228.23% | 5 | Jun 17, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 | $5.59 | +78.89% | 1 | May 18, 2026 | |
| ELMD Electromed | Reiterated: Buy | $38 → $40 | $26.37 | +51.69% | 2 | May 13, 2026 | |
| OPRX OptimizeRx | Reiterated: Buy | $11 → $10 | $9.15 | +9.29% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $32 → $36 | $23.64 | +52.28% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.3933 | +917.04% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 | $10.30 | +35.92% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.9739 | +413.40% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $7.10 | +97.18% | 3 | Jan 21, 2026 |
Varex Imaging
Aug 10, 2026
Downgraded: Hold
Price Target: $18 → $19
Current: $18.42
Upside: +2.61%
LifeMD
Aug 6, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $2.13
Upside: +275.59%
InfuSystem Holdings
Aug 5, 2026
Rated: Buy
Price Target: $12 → $20
Current: $13.94
Upside: +43.47%
Exagen
Aug 5, 2026
Rated: Buy
Price Target: $8 → $12
Current: $7.27
Upside: +65.06%
Anika Therapeutics
Jul 30, 2026
Reiterated: Buy
Price Target: $18 → $21
Current: $21.42
Upside: -1.96%
Nutex Health
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $290
Current: $209.59
Upside: +38.37%
ClearPoint Neuro
Jun 17, 2026
Reiterated: Buy
Price Target: $20 → $30
Current: $9.14
Upside: +228.23%
Orchestra BioMed Holdings
May 18, 2026
Reiterated: Buy
Price Target: $10
Current: $5.59
Upside: +78.89%
Electromed
May 13, 2026
Reiterated: Buy
Price Target: $38 → $40
Current: $26.37
Upside: +51.69%
OptimizeRx
May 13, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $9.15
Upside: +9.29%
May 7, 2026
Upgraded: Buy
Price Target: $32 → $36
Current: $23.64
Upside: +52.28%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.3933
Upside: +917.04%
Feb 26, 2026
Downgraded: Hold
Price Target: $14
Current: $10.30
Upside: +35.92%
Feb 10, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $0.9739
Upside: +413.40%
Jan 21, 2026
Reiterated: Buy
Price Target: $14
Current: $7.10
Upside: +97.18%